Brokerages Set Omega Healthcare Investors, Inc. (NYSE:OHI) Target Price at $39.70

Shares of Omega Healthcare Investors, Inc. (NYSE:OHI) have been assigned an average recommendation of “Hold” from the twelve brokerages that are presently covering the firm, MarketBeat.com reports. Seven research analysts have rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average twelve-month price target among analysts that have updated their coverage on the stock in the last year is $40.00.

OHI has been the topic of a number of recent research reports. BMO Capital Markets upped their target price on Omega Healthcare Investors from $44.00 to $45.00 and gave the stock a “market perform” rating in a research note on Monday, October 7th. Royal Bank of Canada increased their price target on Omega Healthcare Investors from $39.00 to $43.00 and gave the stock a “sector perform” rating in a research report on Monday. Berenberg Bank initiated coverage on Omega Healthcare Investors in a research report on Friday, October 18th. They set a “buy” rating and a $45.00 price target on the stock. Mizuho downgraded Omega Healthcare Investors from an “outperform” rating to a “neutral” rating and increased their price target for the stock from $34.00 to $35.00 in a research report on Thursday, July 25th. Finally, Scotiabank increased their price target on Omega Healthcare Investors from $33.00 to $39.00 and gave the stock a “sector perform” rating in a research report on Monday, August 26th.

Insider Activity at Omega Healthcare Investors

In related news, CFO Robert O. Stephenson sold 22,542 shares of the stock in a transaction that occurred on Friday, September 27th. The stock was sold at an average price of $40.19, for a total value of $905,962.98. Following the completion of the sale, the chief financial officer now owns 183,076 shares of the company’s stock, valued at approximately $7,357,824.44. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In other Omega Healthcare Investors news, COO Daniel J. Booth sold 56,725 shares of the firm’s stock in a transaction on Friday, September 27th. The stock was sold at an average price of $40.25, for a total transaction of $2,283,181.25. Following the completion of the sale, the chief operating officer now owns 100,000 shares of the company’s stock, valued at $4,025,000. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Robert O. Stephenson sold 22,542 shares of the firm’s stock in a transaction on Friday, September 27th. The stock was sold at an average price of $40.19, for a total value of $905,962.98. Following the sale, the chief financial officer now directly owns 183,076 shares of the company’s stock, valued at approximately $7,357,824.44. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders own 1.37% of the company’s stock.

Institutional Investors Weigh In On Omega Healthcare Investors

Several hedge funds and other institutional investors have recently added to or reduced their stakes in OHI. Daiwa Securities Group Inc. increased its stake in Omega Healthcare Investors by 317.7% during the third quarter. Daiwa Securities Group Inc. now owns 3,949,368 shares of the real estate investment trust’s stock worth $160,739,000 after acquiring an additional 3,003,845 shares during the last quarter. Marshall Wace LLP acquired a new stake in Omega Healthcare Investors during the second quarter worth $20,962,000. BROOKFIELD Corp ON acquired a new stake in Omega Healthcare Investors during the first quarter worth $16,446,000. FMR LLC boosted its position in shares of Omega Healthcare Investors by 9.9% during the third quarter. FMR LLC now owns 4,216,835 shares of the real estate investment trust’s stock worth $171,625,000 after buying an additional 380,626 shares during the period. Finally, Dimensional Fund Advisors LP boosted its position in shares of Omega Healthcare Investors by 7.9% during the second quarter. Dimensional Fund Advisors LP now owns 3,732,390 shares of the real estate investment trust’s stock worth $127,831,000 after buying an additional 272,299 shares during the period. Institutional investors and hedge funds own 65.25% of the company’s stock.

Omega Healthcare Investors Stock Down 2.2 %

Shares of OHI opened at $40.07 on Friday. Omega Healthcare Investors has a 52 week low of $27.53 and a 52 week high of $44.42. The company has a quick ratio of 6.48, a current ratio of 6.48 and a debt-to-equity ratio of 1.10. The company has a market capitalization of $10.82 billion, a price-to-earnings ratio of 29.46, a PEG ratio of 1.28 and a beta of 0.99. The stock’s 50-day moving average price is $40.65 and its 200-day moving average price is $36.54.

Omega Healthcare Investors Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Monday, November 4th will be issued a dividend of $0.67 per share. The ex-dividend date of this dividend is Monday, November 4th. This represents a $2.68 dividend on an annualized basis and a dividend yield of 6.69%. Omega Healthcare Investors’s payout ratio is currently 197.06%.

About Omega Healthcare Investors

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.